Tag
Tilray Inc
- Medical cannabis cuts daily opioid‑use in chronic pain patients: study
- Tilray ekes out Q2 profit despite 16% drop in pot sales
- Tilray chosen as supplier of medical pot in Luxembourg
- Tilray signs deal with Great North Distributors to boost Canadian presence
- Tilray hires ex‑Bacardi GM as president
- Tilray says it's fighting 'ankle biters' for sales in Q1 call
- Tilray confirms shutdown of flagship Nanaimo facility
- Hexo to buy 48North Cannabis for $50M
- Aurora stock falls amid more large losses and cost cuts
- Tilray 1.0 quietly discloses first-quarter US$341M loss
- Writedowns and growing pains ahead for Tilray 2.0, analyst says
- Health Canada opens up CBD market with new hemp cultivar approvals
- Tilray reduces required shareholder vote count to 1/3 for Aphria merger
- Hexo touts Q2 earnings, eyes M&A
- Hexo to enter Europe with $265M Zenabis acquisition
- Reddit traders send pot stocks to the moon ‑‑ and back
- Tilray stock soars 40% on UK supply deal with Grow Pharma
- Tilray first company approved to sell medical cannabis in Portugal
- Cannabis significantly reduces prescription opioid use: Tilray patient study
- Aphria stock hits 2‑year high on record Q2 sales
- Hexo, Molson Coors launch first US CBD drinks in Colorado
- Tilray and Aphria unveil merger plan to create world's biggest weed firm
- Medical cannabis can curb drinking and boost public health: study
- Canada squeaks out passing grade on legal cannabis
- Weed stock index surges 7% after Kamala Harris said Biden will decriminalize
- Aphria joins Israeli medical cannabis rush with new supply deal
- Hexo makes first international medical weed shipment to Israel
- Organigram lays off 220 workers, warns of declining weed sales
- Aurora Cannabis to close 5 facilities, lay off 700 staff in search for profits
- Organigram signs 7‑year medical cannabis deal with Israeli firm
- Israel announces plan to legalize weed
- Tilray to shutter Ontario greenhouse as Canadian cannabis closures continue
- Tilray slides on massive Q1 loss, says COVID‑19 hasn't disrupted operations
- As cannabis bankruptcies accelerate during pandemic, lawyer says survivors will thrive long term
- No, cannabis isn't recession proof, analyst says
- COVID‑19 pandemic puts Canadian cannabis operations in limbo
- Canopy launches its first THC‑infused drink nationwide
- Tilray takes a tumble after reporting 2019 losses
- Cannabis market will triple by 2024, pot stocks will rebound: report
- Canadian doctor says Tide Pods pose greater health threat than cannabis edibles
- Investors hold their breath as Tilray, Cronos lead cannabis earnings week with mixed results
- 'We Call the Bottom:' New York Bank Sees Green Days Ahead for Canadian Pot Stocks
- Tilray Backs First Human Study on Cannabis in Breast Cancer Patients
- Amid Legalization 2.0, Half of Canadians Don't Know How to Use Cannabis
- Labatt Breweries and Tilray to Launch CBD‑Infused Tea‑Like Beverage
- Market Capitalization Shrinks by $33.18 Billion For Top 10 Canadian Cannabis Companies Since Legalization